My SciELO
Services on Demand
Journal
Article
Indicators
- Cited by SciELO
- Access statistics
Related links
- Cited by Google
- Similars in SciELO
- Similars in Google
Share
Revista de la Sociedad Española del Dolor
Print version ISSN 1134-8046
Abstract
MEDINA PEREZ, JJ; VEGA ROSAS, GA; MEDINA PEREZ, ME and COUBERT PELAYO, SG. Analgesic effectiveness of tapentadol in neuropathic pain secondary to post-laminectomy syndrome. Rev. Soc. Esp. Dolor [online]. 2021, vol.28, n.2, pp.71-75. Epub June 21, 2021. ISSN 1134-8046. https://dx.doi.org/10.20986/resed.2021.3822/2020.
Objective:
The objective of this study is to evaluate the efficacy and safety of long-acting tapentadol 100 or 200 mg orally every 24 hours for the treatment of Postlaminectomy Syndrome (SPL) in a series of patients with pain neuropathic in ineffective analgesic treatment.
Material and methods:
A single-center, longitudinal, prospective and observational study was conducted, in which 30 patients were recruited to the pain clinic of a third-level reference center who suffered from SPL and who met all the inclusion criteria; To whom the Brief Pain Inventory questionnaire in its Spanish version and the Lanss Test were applied before and after starting treatment with tapentadol and a student's t was applied to compare the overall effectiveness of the treatment of neuropathic pain.
Results:
Data from 30 patients were analyzed, of which 19 were women (63.3 %) and 11 were men (36.6 %) with a diagnosis of confirmed SPL and the presentation of neuropathic pain, who were divided into two groups. The first group of 13 patients (43.3 %) received tapentadol at 100 mg orally every 24 hours, and the second group of 17 patients (56.6 %) received 200 mg orally every 24 hours for four weeks. They were followed up for 4 weeks and statistically significant improvement (p value = 0.05) was found in the SPL clinic.
Keywords : Neuropathic pain; chronic pain; postlaminectomy syndrome; tapentadol; opioids; orthopedic surgery.